human coronavirus 229e Search Results


96
ATCC human coronavirus 229e
Human Coronavirus 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human coronavirus 229e/product/ATCC
Average 96 stars, based on 1 article reviews
human coronavirus 229e - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

95
Sino Biological hcov 229e n
The antiviral effect of Tg against <t>HCoV-229E</t> infection does not require IRE1, ATF6, or PERK expression. (A) Stable UPR knockdown A549 cell lines were generated via lentiviral transduction. Silencing of protein expression was confirmed via western blot. (B–F) A549 shCTRL, shIRE1, shATF6, and shPERK cells were primed with DMSO or Tg (0.05 µM) for 30 minutes, then washed prior to infection with HCoV-229E (MOI 0.05). Cell lysates (B–E) or supernatants (F) were collected at 24 hpi. (B–D) Protein expression of IRE1, ATF6, PERK and HCoV-229E N were assessed by western blot. (E) Changes in gene expression were quantified by RT-qPCR. Data are normalized to actin and set relative to shCTRL DMSO. (F) Supernatants were used to determine viral titers by plaque assay on Huh7 cells. Due to variability between replicates, titration data is expressed as a percentage relative to the shCTRL DMSO in each experiment. Graphs show means ± SD from 3 independent experiments, with qPCR performed in technical triplicate. Statistical significance was assessed by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Hcov 229e N, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcov 229e n/product/Sino Biological
Average 95 stars, based on 1 article reviews
hcov 229e n - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

91
R&D Systems hcov 229e anti spike antibody
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
Hcov 229e Anti Spike Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcov 229e anti spike antibody/product/R&D Systems
Average 91 stars, based on 1 article reviews
hcov 229e anti spike antibody - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier

93
R&D Systems anti hcov 229e spike
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
Anti Hcov 229e Spike, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hcov 229e spike/product/R&D Systems
Average 93 stars, based on 1 article reviews
anti hcov 229e spike - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

94
Sino Biological v08b
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
V08b, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/v08b/product/Sino Biological
Average 94 stars, based on 1 article reviews
v08b - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
Sino Biological hcov 229e spike s1 subunit
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
Hcov 229e Spike S1 Subunit, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcov 229e spike s1 subunit/product/Sino Biological
Average 93 stars, based on 1 article reviews
hcov 229e spike s1 subunit - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Sino Biological expression plasmid sino biological
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
Expression Plasmid Sino Biological, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/expression plasmid sino biological/product/Sino Biological
Average 93 stars, based on 1 article reviews
expression plasmid sino biological - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Sino Biological hcov 229e
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
Hcov 229e, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcov 229e/product/Sino Biological
Average 93 stars, based on 1 article reviews
hcov 229e - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
sino biological 40640-mm11
Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with <t>human</t> <t>coronavirus</t> <t>229E</t> <t>(HCoV-229E)</t> . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection
40640 Mm11, supplied by sino biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/40640-mm11/product/sino biological
Average 93 stars, based on 1 article reviews
40640-mm11 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
ATCC quantitative genomic rna from human coronavirus 229e
List of commercially available molecular standards (nucleic acid solutions) used in analysis of the specificity of the three studied RT-qPCR assays.
Quantitative Genomic Rna From Human Coronavirus 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantitative genomic rna from human coronavirus 229e/product/ATCC
Average 92 stars, based on 1 article reviews
quantitative genomic rna from human coronavirus 229e - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

92
Sino Biological hcov 229e np
Primers used in qRT-PCR assay
Hcov 229e Np, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hcov 229e np/product/Sino Biological
Average 92 stars, based on 1 article reviews
hcov 229e np - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

Image Search Results


The antiviral effect of Tg against HCoV-229E infection does not require IRE1, ATF6, or PERK expression. (A) Stable UPR knockdown A549 cell lines were generated via lentiviral transduction. Silencing of protein expression was confirmed via western blot. (B–F) A549 shCTRL, shIRE1, shATF6, and shPERK cells were primed with DMSO or Tg (0.05 µM) for 30 minutes, then washed prior to infection with HCoV-229E (MOI 0.05). Cell lysates (B–E) or supernatants (F) were collected at 24 hpi. (B–D) Protein expression of IRE1, ATF6, PERK and HCoV-229E N were assessed by western blot. (E) Changes in gene expression were quantified by RT-qPCR. Data are normalized to actin and set relative to shCTRL DMSO. (F) Supernatants were used to determine viral titers by plaque assay on Huh7 cells. Due to variability between replicates, titration data is expressed as a percentage relative to the shCTRL DMSO in each experiment. Graphs show means ± SD from 3 independent experiments, with qPCR performed in technical triplicate. Statistical significance was assessed by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Journal: RSC Chemical Biology

Article Title: Chemical modulation of the unfolded protein response reveals an antiviral role for the PERK pathway in human coronavirus 229E infection

doi: 10.1039/d5cb00242g

Figure Lengend Snippet: The antiviral effect of Tg against HCoV-229E infection does not require IRE1, ATF6, or PERK expression. (A) Stable UPR knockdown A549 cell lines were generated via lentiviral transduction. Silencing of protein expression was confirmed via western blot. (B–F) A549 shCTRL, shIRE1, shATF6, and shPERK cells were primed with DMSO or Tg (0.05 µM) for 30 minutes, then washed prior to infection with HCoV-229E (MOI 0.05). Cell lysates (B–E) or supernatants (F) were collected at 24 hpi. (B–D) Protein expression of IRE1, ATF6, PERK and HCoV-229E N were assessed by western blot. (E) Changes in gene expression were quantified by RT-qPCR. Data are normalized to actin and set relative to shCTRL DMSO. (F) Supernatants were used to determine viral titers by plaque assay on Huh7 cells. Due to variability between replicates, titration data is expressed as a percentage relative to the shCTRL DMSO in each experiment. Graphs show means ± SD from 3 independent experiments, with qPCR performed in technical triplicate. Statistical significance was assessed by two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).

Article Snippet: Primary antibodies against IRE1α (Cell Signaling Technology (CST) 3294, dilution 1 : 1000), ATF6 (CST 8089, dilution 1 : 1000), PERK (CST 5683, dilution 1 : 1000), XBP1s (CST 12782T, dilution 1 : 1000), HERPUD1 (Abcam ab150424, dilution 1 : 1000), HCoV-229E N (SinoBiological 40640-T62, dilution 1 : 10 000), beta-actin (Abcam ab8226, dilution 1 : 5000), alpha-tubulin (Thermo Scientific MA5-31466, dilution 1 : 5000), and GAPDH (Thermo Scientific MA5-15738, dilution 1 : 1000) were used for western blotting.

Techniques: Infection, Expressing, Knockdown, Generated, Transduction, Western Blot, Gene Expression, Quantitative RT-PCR, Plaque Assay, Titration

Pharmacological inhibition of IRE1 or ATF6 does not affect the antiviral activity of Tg against HCoV-229E infection. (A and B) A549 cells were primed with DMSO or Tg (0.05 µM) in the absence or presence of KIRA6 (10 µM) or Ceapin-A7 (6 µM). Cell lysates were collected at 24 hours post-treatment. Xbp1s (A) or HERPUD1 (B) protein expression was assessed by western blot. (C) A549 cells were treated with DMSO, KIRA6 (10 µM), or Ceapin-A7 (6 µM) for 24 hours. Alamar blue assay was used to assess cell viability, which is expressed as a percentage relative to DMSO. (D and F) A549 cells were primed with DMSO or Tg (0.05 µM) in the presence or absence of KIRA6 (10 µM), then washed prior to infection with HCoV-229E (MOI 0.05). Viral inoculum was removed 2 hours later and replaced with media containing DMSO or KIRA6 (10 µM). Cell lysates were collected at 24 hpi to assess XBP1s and N gene expression by RT-qPCR (D and F), or Xbp1s and HCoV-229E N protein expression by western blot (E). (G and I) A549 cells were primed with DMSO or Tg (0.05 µM) in the presence or absence of Ceapin-A7 (6 µM), then washed prior to infection with HCoV-229E (MOI 0.05). Viral inoculum was removed 2 hours later and replaced with media containing DMSO or Ceapin-A7 (6 µM). Cell lysates were collected at 24 hpi to assess HERPUD1 and N expression by RT-qPCR (G and I), or HERPUD1 and HCoV-229E N protein expression by western blot (H). RT-qPCR data are normalized to actin and set relative to DMSO. (J) A549 cells were primed with DMSO or Tg (0.05 µM) in the presence or absence of KIRA6 (10 µM) or Ceapin-A7 (6 µM), alone or in combination, prior to infection with HCoV-229E (MOI 0.05). Inoculum was removed 2 hours later and replaced with media containing the respective inhibitor(s). Viral supernatants were collected 24 hpi and titrated by plaque assay on Huh7 cells. Graphs show mean ± SD from 2–3 independent experiments performed in triplicate, with qPCR performed in technical triplicate (* p < 0.05, *** p < 0.001; **** p < 0.0001). Representative western blots are shown.

Journal: RSC Chemical Biology

Article Title: Chemical modulation of the unfolded protein response reveals an antiviral role for the PERK pathway in human coronavirus 229E infection

doi: 10.1039/d5cb00242g

Figure Lengend Snippet: Pharmacological inhibition of IRE1 or ATF6 does not affect the antiviral activity of Tg against HCoV-229E infection. (A and B) A549 cells were primed with DMSO or Tg (0.05 µM) in the absence or presence of KIRA6 (10 µM) or Ceapin-A7 (6 µM). Cell lysates were collected at 24 hours post-treatment. Xbp1s (A) or HERPUD1 (B) protein expression was assessed by western blot. (C) A549 cells were treated with DMSO, KIRA6 (10 µM), or Ceapin-A7 (6 µM) for 24 hours. Alamar blue assay was used to assess cell viability, which is expressed as a percentage relative to DMSO. (D and F) A549 cells were primed with DMSO or Tg (0.05 µM) in the presence or absence of KIRA6 (10 µM), then washed prior to infection with HCoV-229E (MOI 0.05). Viral inoculum was removed 2 hours later and replaced with media containing DMSO or KIRA6 (10 µM). Cell lysates were collected at 24 hpi to assess XBP1s and N gene expression by RT-qPCR (D and F), or Xbp1s and HCoV-229E N protein expression by western blot (E). (G and I) A549 cells were primed with DMSO or Tg (0.05 µM) in the presence or absence of Ceapin-A7 (6 µM), then washed prior to infection with HCoV-229E (MOI 0.05). Viral inoculum was removed 2 hours later and replaced with media containing DMSO or Ceapin-A7 (6 µM). Cell lysates were collected at 24 hpi to assess HERPUD1 and N expression by RT-qPCR (G and I), or HERPUD1 and HCoV-229E N protein expression by western blot (H). RT-qPCR data are normalized to actin and set relative to DMSO. (J) A549 cells were primed with DMSO or Tg (0.05 µM) in the presence or absence of KIRA6 (10 µM) or Ceapin-A7 (6 µM), alone or in combination, prior to infection with HCoV-229E (MOI 0.05). Inoculum was removed 2 hours later and replaced with media containing the respective inhibitor(s). Viral supernatants were collected 24 hpi and titrated by plaque assay on Huh7 cells. Graphs show mean ± SD from 2–3 independent experiments performed in triplicate, with qPCR performed in technical triplicate (* p < 0.05, *** p < 0.001; **** p < 0.0001). Representative western blots are shown.

Article Snippet: Primary antibodies against IRE1α (Cell Signaling Technology (CST) 3294, dilution 1 : 1000), ATF6 (CST 8089, dilution 1 : 1000), PERK (CST 5683, dilution 1 : 1000), XBP1s (CST 12782T, dilution 1 : 1000), HERPUD1 (Abcam ab150424, dilution 1 : 1000), HCoV-229E N (SinoBiological 40640-T62, dilution 1 : 10 000), beta-actin (Abcam ab8226, dilution 1 : 5000), alpha-tubulin (Thermo Scientific MA5-31466, dilution 1 : 5000), and GAPDH (Thermo Scientific MA5-15738, dilution 1 : 1000) were used for western blotting.

Techniques: Inhibition, Activity Assay, Infection, Expressing, Western Blot, Alamar Blue Assay, Gene Expression, Quantitative RT-PCR, Plaque Assay

Pharmacological activation of PERK inhibits HCoV-229E replication. (A–C) A549 cells were treated with DMSO or one of the selective UPR activators for 24 hours. IXA4 (10 µM) activates IRE1, AA147 (10 µM) activates ATF6, and CCT020312 (5 µM) activates PERK. RNA lysates were collected 24 hours post-treatment and the expression of genes downstream of each UPR pathway was assessed by RT-qPCR. Data are normalized to actin and set relative to DMSO. (D) A549 cells were primed with Tg (0.5 µM) for 30 minutes, then washed and infected with HCoV-229E (MOI 0.5). Alternatively, cells were treated with AA147 (10 µM) or CCT020312 (5 µM) for 24 hpi. Cell lysates were collected to assess the expression of HERPUD1, PERK and 229E N protein by western blot. (F and G) A549 cells were primed with DMSO or Tg (0.05 µM) for 30 minutes prior to infection with HCoV-229E (MOI 0.05). Alternatively, cells were infected and then treated with media containing DMSO or the selective UPR activators alone or in combination. Cell lysates and supernatants were collected at 24 hpi. (F) Changes in HCoV-229E N gene expression were assessed by RT-qPCR. Data are normalized to actin and set relative to DMSO. (F) Viral titer was assessed by plaque assay on Huh7 cells. (H–J) A549 cells were infected with HCoV-229E (MOI 0.05), then incubated with increasing concentrations of CCT020312 for 24 h. Cell lysates were collected to assess changes in HCoV-229E N gene (H) and CHOP (I) expression by RT-qPCR. (J) Cell viability was assessed by Alamar blue assay. Graphs show means ± SD from 2–3 independent experiments performed in triplicate, with qPCR performed in technical triplicate. Statistical significance was assessed by one-way ANOVA or t -test (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001).

Journal: RSC Chemical Biology

Article Title: Chemical modulation of the unfolded protein response reveals an antiviral role for the PERK pathway in human coronavirus 229E infection

doi: 10.1039/d5cb00242g

Figure Lengend Snippet: Pharmacological activation of PERK inhibits HCoV-229E replication. (A–C) A549 cells were treated with DMSO or one of the selective UPR activators for 24 hours. IXA4 (10 µM) activates IRE1, AA147 (10 µM) activates ATF6, and CCT020312 (5 µM) activates PERK. RNA lysates were collected 24 hours post-treatment and the expression of genes downstream of each UPR pathway was assessed by RT-qPCR. Data are normalized to actin and set relative to DMSO. (D) A549 cells were primed with Tg (0.5 µM) for 30 minutes, then washed and infected with HCoV-229E (MOI 0.5). Alternatively, cells were treated with AA147 (10 µM) or CCT020312 (5 µM) for 24 hpi. Cell lysates were collected to assess the expression of HERPUD1, PERK and 229E N protein by western blot. (F and G) A549 cells were primed with DMSO or Tg (0.05 µM) for 30 minutes prior to infection with HCoV-229E (MOI 0.05). Alternatively, cells were infected and then treated with media containing DMSO or the selective UPR activators alone or in combination. Cell lysates and supernatants were collected at 24 hpi. (F) Changes in HCoV-229E N gene expression were assessed by RT-qPCR. Data are normalized to actin and set relative to DMSO. (F) Viral titer was assessed by plaque assay on Huh7 cells. (H–J) A549 cells were infected with HCoV-229E (MOI 0.05), then incubated with increasing concentrations of CCT020312 for 24 h. Cell lysates were collected to assess changes in HCoV-229E N gene (H) and CHOP (I) expression by RT-qPCR. (J) Cell viability was assessed by Alamar blue assay. Graphs show means ± SD from 2–3 independent experiments performed in triplicate, with qPCR performed in technical triplicate. Statistical significance was assessed by one-way ANOVA or t -test (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001).

Article Snippet: Primary antibodies against IRE1α (Cell Signaling Technology (CST) 3294, dilution 1 : 1000), ATF6 (CST 8089, dilution 1 : 1000), PERK (CST 5683, dilution 1 : 1000), XBP1s (CST 12782T, dilution 1 : 1000), HERPUD1 (Abcam ab150424, dilution 1 : 1000), HCoV-229E N (SinoBiological 40640-T62, dilution 1 : 10 000), beta-actin (Abcam ab8226, dilution 1 : 5000), alpha-tubulin (Thermo Scientific MA5-31466, dilution 1 : 5000), and GAPDH (Thermo Scientific MA5-15738, dilution 1 : 1000) were used for western blotting.

Techniques: Activation Assay, Expressing, Quantitative RT-PCR, Infection, Western Blot, Gene Expression, Plaque Assay, Incubation, Alamar Blue Assay

UPR activation by tunicamycin does not recapitulate the antiviral effect of Tg. (A–C) A549 cells were primed with Tg (0.5 µM) for 30 minutes or with Tm (1 µg mL −1 ) for 4 hours. Cells were then washed and either mock-infected or infected with HCoV-229E (MOI 0.05). At 24 hpi, cell lysates were collected to evaluate expression of UPR target genes ( CHOP , HERPUD1 and Xbp1s ) or HCoV-229E N gene by qPCR. Graphs show means ± SD from 2 independent experiments, with qPCR performed in technical triplicate. Statistical significance was assessed by one-way or two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001).

Journal: RSC Chemical Biology

Article Title: Chemical modulation of the unfolded protein response reveals an antiviral role for the PERK pathway in human coronavirus 229E infection

doi: 10.1039/d5cb00242g

Figure Lengend Snippet: UPR activation by tunicamycin does not recapitulate the antiviral effect of Tg. (A–C) A549 cells were primed with Tg (0.5 µM) for 30 minutes or with Tm (1 µg mL −1 ) for 4 hours. Cells were then washed and either mock-infected or infected with HCoV-229E (MOI 0.05). At 24 hpi, cell lysates were collected to evaluate expression of UPR target genes ( CHOP , HERPUD1 and Xbp1s ) or HCoV-229E N gene by qPCR. Graphs show means ± SD from 2 independent experiments, with qPCR performed in technical triplicate. Statistical significance was assessed by one-way or two-way ANOVA (* p < 0.05, ** p < 0.01, *** p < 0.001; **** p < 0.0001).

Article Snippet: Primary antibodies against IRE1α (Cell Signaling Technology (CST) 3294, dilution 1 : 1000), ATF6 (CST 8089, dilution 1 : 1000), PERK (CST 5683, dilution 1 : 1000), XBP1s (CST 12782T, dilution 1 : 1000), HERPUD1 (Abcam ab150424, dilution 1 : 1000), HCoV-229E N (SinoBiological 40640-T62, dilution 1 : 10 000), beta-actin (Abcam ab8226, dilution 1 : 5000), alpha-tubulin (Thermo Scientific MA5-31466, dilution 1 : 5000), and GAPDH (Thermo Scientific MA5-15738, dilution 1 : 1000) were used for western blotting.

Techniques: Activation Assay, Infection, Expressing

Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with human coronavirus 229E (HCoV-229E) . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection

Journal: European Journal of Microbiology & Immunology

Article Title: Phytochemicals and micronutrients in suppressing infectivity caused by SARS-CoV-2 virions and seasonal coronavirus HCoV-229E in vivo

doi: 10.1556/1886.2023.00010

Figure Lengend Snippet: Effect of test composition on weight change, viral load and spike protein in lung tissue infected and re-infected with human coronavirus 229E (HCoV-229E) . A. Effect of four-days of oral administration of MixV in K18-hACE2 mice with no significant weight change after 3 dpi and 5 dpi and oral administration of MixV with mid-term re-infection. B. The viral load in lung tissue after 3 dpi with oral administration of MixV and 5 dpi with oral administration and mid-term re-infection, determined by RT-qPCR as described in Materials and Methods section. C. Spike protein detection by WB in representative lung tissue samples. D. Quantification of spike protein performed as described in Materials and Methods section. Data are presented as mean ± SD; infected untreated animal n = 8, infected treated animal n = 8, re-infected untreated animal n = 8, re-infected treated animal n = 8; # P ≤ 0.05, ∆ P ≤ 0.01, dpi - days post-infection

Article Snippet: HCoV-229E anti-spike antibody was acquired from R&D Systems (Minneapolis, MN, USA).

Techniques: Infection, Quantitative RT-PCR

List of commercially available molecular standards (nucleic acid solutions) used in analysis of the specificity of the three studied RT-qPCR assays.

Journal: Scientific Reports

Article Title: Commercially available SARS-CoV-2 RT-qPCR diagnostic tests need obligatory internal validation

doi: 10.1038/s41598-023-34220-w

Figure Lengend Snippet: List of commercially available molecular standards (nucleic acid solutions) used in analysis of the specificity of the three studied RT-qPCR assays.

Article Snippet: Quantitative Genomic RNA from Human coronavirus 229E , ATCC-VR-740DQ.

Techniques: Virus

RT-qPCR amplification parameters for Novel  Coronavirus  (2019-nCoV) Real Time Multiplex RT-PCR Kit (Liferiver), Vitassay qPCR SARS-CoV-2 (Vitassay) and TaqPath COVID‑19 CE-IVD RT-PCR Kit (Thermo Fisher Scientific).

Journal: Scientific Reports

Article Title: Commercially available SARS-CoV-2 RT-qPCR diagnostic tests need obligatory internal validation

doi: 10.1038/s41598-023-34220-w

Figure Lengend Snippet: RT-qPCR amplification parameters for Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit (Liferiver), Vitassay qPCR SARS-CoV-2 (Vitassay) and TaqPath COVID‑19 CE-IVD RT-PCR Kit (Thermo Fisher Scientific).

Article Snippet: Quantitative Genomic RNA from Human coronavirus 229E , ATCC-VR-740DQ.

Techniques: Amplification, Multiplex Assay

Primers used in qRT-PCR assay

Journal: Virology Journal

Article Title: Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2

doi: 10.1186/s12985-025-02673-2

Figure Lengend Snippet: Primers used in qRT-PCR assay

Article Snippet: The primary antibodies used were antibodies against glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling Technology, Boston, MA, USA, 1:1000), HCoV-229E NP (Sino Biological, Beijing, China, 1:8000), HCoV-OC43 nucleocapsid protein (NP; Millipore, Billerica, MA, USA,1:1000), and IMPDH2 (Abcam, Cambridge, UK, 1:1000).

Techniques: Sequencing

The antiviral activity of MMF is achieved by non-competitive inhibition of the IMPDH enzyme. a Schematic diagram of time-of-addition assay. b , c Time-of-addition assay of MMF. Cells were seeded onto 96-well plates and infected with HCoV-229E or HCoV-OC43 (MOI = 3.5) for 1 h on ice. 5 μM MMF was added at different time points and cells were fixed at 9 h. Intracellular viral NP protein was detected with immunofluorescence (IF) assay. Green particles represent NP and the blue ones represent cell nucleus. The quantitative study on immunofluorescence was comparison of the total fluorescence values of each experimental group with the control group and analyzed by Image J software. d , e CETSA assay to detect the binding between IMPDH and MMF in the cell lysis of Huh7.5 and H460. Each lane represents the protein level of IMPDH at various temperatures after incubation with MMF or DMSO control, and relative density of IMPDH was normalized by the protein gray value at 47 °C ( n = 3). f , g Cells were infected with HCoV-229E (MOI = 0.35) or HCoV-OC43 (MOI = 0.35), and treated with different concentrations of guanosine and MMF for 24 h. The cells were harvested for western blotting assay ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. virus control (Con) or # P < 0.05, ## P < 0.01, ### P < 0.001 vs. MMF treated group (The third group), one-way ANOVA with Holm-Sidak multiple comparisons test

Journal: Virology Journal

Article Title: Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2

doi: 10.1186/s12985-025-02673-2

Figure Lengend Snippet: The antiviral activity of MMF is achieved by non-competitive inhibition of the IMPDH enzyme. a Schematic diagram of time-of-addition assay. b , c Time-of-addition assay of MMF. Cells were seeded onto 96-well plates and infected with HCoV-229E or HCoV-OC43 (MOI = 3.5) for 1 h on ice. 5 μM MMF was added at different time points and cells were fixed at 9 h. Intracellular viral NP protein was detected with immunofluorescence (IF) assay. Green particles represent NP and the blue ones represent cell nucleus. The quantitative study on immunofluorescence was comparison of the total fluorescence values of each experimental group with the control group and analyzed by Image J software. d , e CETSA assay to detect the binding between IMPDH and MMF in the cell lysis of Huh7.5 and H460. Each lane represents the protein level of IMPDH at various temperatures after incubation with MMF or DMSO control, and relative density of IMPDH was normalized by the protein gray value at 47 °C ( n = 3). f , g Cells were infected with HCoV-229E (MOI = 0.35) or HCoV-OC43 (MOI = 0.35), and treated with different concentrations of guanosine and MMF for 24 h. The cells were harvested for western blotting assay ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. virus control (Con) or # P < 0.05, ## P < 0.01, ### P < 0.001 vs. MMF treated group (The third group), one-way ANOVA with Holm-Sidak multiple comparisons test

Article Snippet: The primary antibodies used were antibodies against glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling Technology, Boston, MA, USA, 1:1000), HCoV-229E NP (Sino Biological, Beijing, China, 1:8000), HCoV-OC43 nucleocapsid protein (NP; Millipore, Billerica, MA, USA,1:1000), and IMPDH2 (Abcam, Cambridge, UK, 1:1000).

Techniques: Activity Assay, Inhibition, Infection, Immunofluorescence, Comparison, Fluorescence, Control, Software, Binding Assay, Lysis, Incubation, Western Blot, Virus

Anti-coronavirus activities of MPA and MMF

Journal: Virology Journal

Article Title: Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2

doi: 10.1186/s12985-025-02673-2

Figure Lengend Snippet: Anti-coronavirus activities of MPA and MMF

Article Snippet: The primary antibodies used were antibodies against glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling Technology, Boston, MA, USA, 1:1000), HCoV-229E NP (Sino Biological, Beijing, China, 1:8000), HCoV-OC43 nucleocapsid protein (NP; Millipore, Billerica, MA, USA,1:1000), and IMPDH2 (Abcam, Cambridge, UK, 1:1000).

Techniques:

MMF and MPA inhibited viral protein levels and viral yield of HCoV-229E and HCoV-OC43. Cells were infected with HCoV-229E (MOI = 0.35) or HCoV-OC43 (MOI = 0.35), and treated with different concentrations of MMF or MPA for 24 h. a–f The cells were harvested for western blotting assay ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. virus control (Con), one-way ANOVA with Holm-Sidak multiple comparisons test. g–j The cells were fixed and NP was detected with immunofluorescence (IF) assay. Green particles represent NP and the blue ones represent cell nucleus. The quantitative study on immunofluorescence was comparison of the total fluorescence values of each experimental group with the control group and analyzed by Image J software. k–l Viral titers were detected by the 50% tissue culture infectious dose assay (TCID 50 ) ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. virus control (Con), one-way ANOVA with Holm-Sidak multiple comparisons test

Journal: Virology Journal

Article Title: Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2

doi: 10.1186/s12985-025-02673-2

Figure Lengend Snippet: MMF and MPA inhibited viral protein levels and viral yield of HCoV-229E and HCoV-OC43. Cells were infected with HCoV-229E (MOI = 0.35) or HCoV-OC43 (MOI = 0.35), and treated with different concentrations of MMF or MPA for 24 h. a–f The cells were harvested for western blotting assay ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. virus control (Con), one-way ANOVA with Holm-Sidak multiple comparisons test. g–j The cells were fixed and NP was detected with immunofluorescence (IF) assay. Green particles represent NP and the blue ones represent cell nucleus. The quantitative study on immunofluorescence was comparison of the total fluorescence values of each experimental group with the control group and analyzed by Image J software. k–l Viral titers were detected by the 50% tissue culture infectious dose assay (TCID 50 ) ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 vs. virus control (Con), one-way ANOVA with Holm-Sidak multiple comparisons test

Article Snippet: The primary antibodies used were antibodies against glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling Technology, Boston, MA, USA, 1:1000), HCoV-229E NP (Sino Biological, Beijing, China, 1:8000), HCoV-OC43 nucleocapsid protein (NP; Millipore, Billerica, MA, USA,1:1000), and IMPDH2 (Abcam, Cambridge, UK, 1:1000).

Techniques: Infection, Western Blot, Virus, Control, Immunofluorescence, Comparison, Fluorescence, Software

Combinatorial effects of MMF and other antiviral compounds. a , b Dose–response matrixs and dose–response curves of combination of MMF and molnupiravir. c , d Dose–response matrixs and dose–response curves of combination of MMF and GC376. e , f Dose–response matrixs and dose–response curves of combination of MMF and E64d. In detail, Huh7.5 cells were infected with HCoV-229E (MOI = 0.35) for 24 h (a, c, e, n = 3, mean ± SD) and H460 cells were infected with HCoV-OC43 for 24 h (MOI = 0.35) (b, d, f, n = 3, mean ± SD). The horizontal and vertical coordinates of the dose–response matrix are the concentrations of the combined drugs. NP mRNA levels was determined by qRT-PCR assay and relative quantification. The inhibition of virus replication of non-administrated group was regarded as zero to calculate the inhibition of each administration group

Journal: Virology Journal

Article Title: Mycophenolate mofetil exerts broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2

doi: 10.1186/s12985-025-02673-2

Figure Lengend Snippet: Combinatorial effects of MMF and other antiviral compounds. a , b Dose–response matrixs and dose–response curves of combination of MMF and molnupiravir. c , d Dose–response matrixs and dose–response curves of combination of MMF and GC376. e , f Dose–response matrixs and dose–response curves of combination of MMF and E64d. In detail, Huh7.5 cells were infected with HCoV-229E (MOI = 0.35) for 24 h (a, c, e, n = 3, mean ± SD) and H460 cells were infected with HCoV-OC43 for 24 h (MOI = 0.35) (b, d, f, n = 3, mean ± SD). The horizontal and vertical coordinates of the dose–response matrix are the concentrations of the combined drugs. NP mRNA levels was determined by qRT-PCR assay and relative quantification. The inhibition of virus replication of non-administrated group was regarded as zero to calculate the inhibition of each administration group

Article Snippet: The primary antibodies used were antibodies against glyceraldehyde-3-phosphate dehydrogenase (Cell Signaling Technology, Boston, MA, USA, 1:1000), HCoV-229E NP (Sino Biological, Beijing, China, 1:8000), HCoV-OC43 nucleocapsid protein (NP; Millipore, Billerica, MA, USA,1:1000), and IMPDH2 (Abcam, Cambridge, UK, 1:1000).

Techniques: Infection, Quantitative RT-PCR, Inhibition, Virus